A retrospective study on two cohorts of immunocompetent women treated with nonavalent HPV vaccine vs. Ellagic acid complex: outcome of the evolution of persistent cervical HPV infection

CONCLUSIONS: Despite the limited sample of women enrolled for the present study, the results confirmed the clinical usefulness of HPV vaccination as adjuvant agent for the immune system of women affected by persistent HPV infection. Moreover, in women who refused to be vaccinated, the administration of a biocompound like Ellagic acid plus Annona Muricata, represented an interesting clinical strategy in terms of increasing chance of HPV viral clearance.PMID:35993648 | DOI:10.26355/eurrev_202208_29422

Source: Pharmacological Reviews - August 22, 2022 Category: Drugs & Pharmacology Authors: G M F Moscato F Galanti A A Criscuolo M Ciotti S Riccio R Sorge M Andreoni F Sesti Source Type: research